gRNA Market
The gRNA (guide RNA) market encompasses products and services essential for CRISPR-Cas9 gene editing technology. Key customers include pharmaceutical and biotechnology companies, academic research institutes, and contract research/manufacturing organizations (CROs/CMOs). Market growth is primarily driven by escalating R&D investments in biotech, the democratization of gene editing through user-friendly synthesis kits, and the increasing adoption of Next-Generation Sequencing (NGS) for genomic analysis.
CAGR
20.4%
Compound Annual Growth Rate
Current Value
$850.0M
Estimated 2026
Projected Value
$3.75B
By 2034